Market Insights Health Medical Technology Medical Devices

Orthopedic Devices - France

France

The projected revenue in the Orthopedic Devices market market in France is expected to reach €1.55bn by 2024.
It is anticipated to exhibit an annual growth rate of 2.46% (CAGR 2024-2029), leading to a market volume of €1.75bn by 2029.
When compared globally, the United States is projected to generate the highest revenue in this market, amounting to €14,850.00m in 2024.
France's strong focus on innovation and technology has propelled the orthopedic devices market to experience steady growth and adoption of advanced medical technologies.

Key regions: France, Netherlands, Europe, Germany, Japan

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Orthopedic Devices market in France is experiencing steady growth due to several key factors.

Customer preferences: Customers in France have a strong preference for high-quality orthopedic devices that offer advanced technology and innovative features. They prioritize products that provide effective solutions for musculoskeletal conditions and injuries, allowing them to maintain an active and healthy lifestyle. Additionally, customers in France value products that are comfortable, durable, and easy to use. They also appreciate personalized and customized solutions that cater to their specific needs and preferences.

Trends in the market: One of the major trends in the Orthopedic Devices market in France is the increasing demand for minimally invasive surgical procedures. This trend is driven by the desire for shorter recovery times, reduced scarring, and less post-operative pain. Minimally invasive procedures also offer the advantage of smaller incisions, which result in lower risk of infection and complications. As a result, there is a growing demand for orthopedic devices that are specifically designed for use in minimally invasive surgeries. Another trend in the market is the rising adoption of robotics and digital technologies in orthopedic procedures. Robotic-assisted surgeries offer improved precision, accuracy, and control, resulting in better patient outcomes. These technologies also enable surgeons to plan and execute complex procedures with greater efficiency. As a result, there is a growing demand for orthopedic devices that are compatible with robotic systems and can facilitate the use of digital technologies in surgical procedures.

Local special circumstances: France has a well-established healthcare system that provides universal coverage for its citizens. This ensures that patients have access to orthopedic devices and treatments, regardless of their financial situation. The government also plays an active role in regulating the orthopedic devices market to ensure patient safety and product quality. This regulatory environment promotes innovation and ensures that only high-quality devices are available in the market.

Underlying macroeconomic factors: France has a large and aging population, which is a key driver of growth in the Orthopedic Devices market. As the population ages, the incidence of musculoskeletal conditions and injuries increases, leading to a higher demand for orthopedic devices. Additionally, the government's focus on improving healthcare infrastructure and increasing healthcare spending further supports the growth of the market. In conclusion, the Orthopedic Devices market in France is driven by customer preferences for high-quality, innovative products, as well as the increasing demand for minimally invasive procedures and the adoption of robotics and digital technologies. The local special circumstances, such as the universal healthcare coverage and regulatory environment, contribute to the growth of the market. The underlying macroeconomic factors, including the aging population and government investments in healthcare, also play a significant role in driving the market's development.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.